Category Archives: Spotlight Interviews

Post-Webinar Spotlight Interview with Robert Gaertner

What is the biggest challenge your industry is facing today?
The biggest challenge for life sciences is understanding the true pace of change. Similar to other industries, new players entering the market impact business operations of the existing companies. If you talk to any pharma executive, they will tell you they want their companies to be as agile and fast as start-ups. The challenge is that neither the internal processes nor the IT systems, in GxP industries are designed to support change and agility.

What are the key discussion points of this webinar?
The pharma industry is undergoing a transformation that has a significant impact on the effectiveness and efficiency of change management. In this webinar, we explore why change management needs to be modernized and key steps required to achieve this.

What do the audience gain from attending your webinar?
Understanding that we have a diverse audience from different professional backgrounds, we decided to focus on the post-approval change management that runs across the entire pharmaceutical value chain. I hope the audience comes away with a better understanding of the benefits that can be achieved by streamlining change management processes and how technology can play a big role in fixing the underlying issues.

What is your favourite part about presenting to a live audience?
Q&A is always my favourite part of the webinar. This is my chance to get feedback on the presentation and continue the discussion on the topics presented in greater depth by helping to uncover answers to some burning questions from the audience. I liked the question about the positioning of regulatory agencies and inspectors in regard to new ways of managing data. Their guidance will indeed be critical for accelerating or slowing down digital transformation in GxP-regulated areas.

How can others learn more about change management?
If they were unable to join the live webinar, I would encourage everyone to watch the recording. I would also like to continue this conversation and happy to be contacted on [email protected] with any questions.

Russ LaBaume, Key Account Management USA – NDT Global

A conversation with Russ LaBaume, Key Account Management USA at NDT Global.

Russ LaBaume has been working as a key account manager with NDT Global for the almost 4 years. He has spent this time focusing on onshore and offshore pipelines throughout the United States of America. Russ is a key member of our Account management team, his clients hold his knowledge, advice and experience with high regard.

He is passionate about utilizing previous experience he gained in business management to cultivate an environment both internally and externally that promotes excitement and enthusiasm while maintaining integrity and efficiencies for NDT Global.

BRW: What do you hope the audience will learn from this webinar?

I hope the audience will gain a better understanding of the advantages to using Ultrasonic Geometry for pipeline inspections. For a pipeline inspection to be successful, operators must collect the best data quality available to feed into their integrity management programs. During this webinar, we will be exploring the limitations and advantages of using both Ultrasonic and Caliper based Geometry Inspection Technologies. We will also look at the value for cost when choosing an Ultrasonic Technology.

BRW: What discussions do you look forward to having with the audience?

At NDT Global, we have worked extremely hard to bring what we believe is first in class ILI technology to the market and I am looking forward to hearing customer insights.

Ultrasonic Geometry is such an interesting topic and one that I really enjoy exploring with my clients. I am really excited to understand how attendees are currently managing their Geometry Inspections. I look forward to hearing the thoughts and perceptions around the advantages of increased resolution and gather feedback on the use of ‘touchless’ technology vs. existing mechanical calipers.

BRW: What do you enjoy most about your role?

Throughout my career, I have learned that although there is no ‘one size fits all’, we have a unique opportunity to learn something new from every client we work with. We are committed to keep NDT Global ahead and bring our clients new and exciting solutions. I often gain the opportunity to educate my clients on the advancements in ILI technology and also work closely to develop solutions to meet our clients’ needs for better pipeline integrity.

BRW: How did you get into the industry?

I believe that in life there is always something new to learn and explore. My previous roles have given me experience in many aspects of business, product development, and services. I joined NDT Global as I am always looking for challenging opportunities and NDT Global has given me the prospect of expanding my knowledge and utilizing my abilities to make a difference in the world.

BRW: Where is your favourite place in the world and why?

I have been extremely fortunate to have the opportunity to experience many new cultures and cities in both my work and private life. For me, I am most at ease, behind the handlebars of my Harley Davidson. My wife and I have over 200,000 miles of new experiences riding to faraway places and seeing sights we would not otherwise have known.  The beauty of this world continues to amaze me.

Russ LaBaume will present a webinar entitled A New Level Of Accuracy For Geometry Inspections With Ultrasonic Technology‘ on the 18th September at 3PM London/10AM New York

Register Here!

John Smythe – Vice President, Technical Marketing & Sales, Fairfield Geotechnologies

A conversation with John Smythe, Vice President, Technical Marketing and Sales at  Fairfield Geotechnologies

John Smythe has 39 years of diverse industry experience working as a geophysicist for Amoco Production Co., BP and EOG Resources. He has been with Fairfield Geotechnologies for 21 years where he is currently Vice President of Technical Marketing and Sales. John has a B.A. in geology from Boston University and an M.S. in Geology from Rensselaer Polytechnic Institute.

BRW: What do you hope the audience will learn from this webinar?

I hope attendees of the webinar will gain insight into how OBN technology is changing the way oil field operators and exploration companies are managing their risk. Nodes have been widely adopted for field development because of the accessibility and 4D repeatability that can only be achieved with nodes. However, new OBN systems with enhanced features bring significant advantages to exploration scale surveys as well.

BRW: What discussions do you look forward to having with the audience?

I hope attendees will share their experiences with field development and how seismic technologies, of all types, have impacted their decision making.  I believe the audience will gain an appreciation, from real experiences, how superior seismic data can dramatically affect and extend the life of their fields.

BRW: What do you enjoy most about your role?

I’ve been fortunate in my career to witness a true step-change in technology. I enjoy participating in the roll-out of new technology and seeing what the impact has been for our clients.

BRW: How did you get into the industry?

After I received my MS in geology I was recruited by Amoco Production Company to work as a geophysicist/interpreter in Houston, TX.  I’ve spent my entire career in the upstream end of the oil and gas business.

BRW: Where is your favourite place in the world and why?

I love the cultural diversity of Indonesia and the people and food of Vietnam. I’ve had occasion to visit both countries and would welcome the chance to return at any time.

Join John Smythe who will present a webinar entitled Revitalizing Mature Basins and Fields Using Scalable Seismic Solutions’ on 3PM London/10AM New York.

Register Here!

Expert interview with Sqn Ldr Robert M Gifford, of Defence Medical Services, and the University of Edinburgh Centre of Cardiovascular Sciences

 

  1. Please give a brief overview of what your session will cover at Medical Innovation 2018?

The endocrine effects of arduous military training on women: evidence from Antarctica and  Sandhurst

High rates of adverse reproductive, psychological and bone health-related outcomes have been reported in military women, compared with men or civilian women. While the reasons for this are poorly understood, hormones are thought to be responsible, since they mediate differences in sex.  Sqn Ldr Gifford will present data from two observational studies which have attempted to understand the nuances of female hormone physiology in arduous training and their impact on reproduction, stress and bone.

The Army Ice Maidens were the all-female first team to complete an Antarctic ski traverse unassisted. The expedition provided a unique investigation of the absolute extremes of exercise, with detailed dynamic hormone testing, body composition measurement and high resolution bone architecture scans to explore the impact of the expedition on women and the rates of recovery.

The Commissioning Course at the Royal Military Academy, Sandhurst is an arduous, year-long basic military training course undertaken by male and female Officer Cadets. The Female Endocrinology in Arduous Training (FEAT) Study’s objective is to understand the reproductive, stress, bone health and nutritional changes in 60 women in military training ab initio. The preliminary findings compare a subgroup with a cohort of 10 men.

The session will describe the studies from Antarctica and sex comparator aspects of the FEAT Study and discuss their findings, before exploring the implications for women entering arduous training.

2. What do you think understanding the future of such an unexplored topic looks like, and how will it shape the way medical practices develop?  

 From what is already known, women and men experience different medical outcomes during military training and employment. By understanding the biological underpinning these differences we aim to develop evidence-based mitigation strategies to promote training equity (rather than just equal opportunities). As well as protecting our women from injury and illness, an improved understanding of the aetiology will equip policymakers and individuals to make evidence-based decisions about training and employment. Furthermore, studies like these may allow medical practice and military training design to become more closely aligned. Emerging technologies like mobile health applications and sensors can enable long term data collection, allowing doctors to assess and improve training outcomes. Using these data we could ultimately generate tailorable training programmes to avoid undue risk to Defence personnel without compromising combat effectiveness.

3. What is your understanding of ‘prolonged care’ and ‘preparedness’ and its relevance to the wider medical community? Any recently publicised events are welcome examples.

The causes of many psychological and musculoskeletal injuries are related to individual physiology, however the precise causal pathways are poorly understood. Our research aims to understand the features of arduous military training and employment which cause physiological strain. Understanding risk factors will allow prolonged field care (PFC) providers to identify and manage risk, allow medical operations to be planned and commanded with a better expectation of risks to individuals, and identify ‘left of bang’ interventions, by describing and mitigating individuals’ injury risks during selection and training.

The Ice Maidens recently demonstrated exceptional biological resilience during an exceptionally arduous exercise exposure – far greater than has been seen in specialist military training. The reasons for this could be simple factors, for example they had an incremental training package rather than an abrupt-onset one, and they were afforded appropriate rest, where possible. These may be salutary lessons for preventing injury in the field.

Through the FEAT Study, we aim to validate and deliver mobile health applications which we hope could facilitate data collection across meaningful durations of training and deployment, and implement positive behavioural change to mitigate against illness or injury. Such platforms could also have great benefits to PFC delivery, allowing data collection from PFC providers.

4. What developments have been made in medical innovation in the last 12 months that particularly stand out, and why?

A study using mobile apps for research data collection has recently been published in the Canadian Armed Forces (Ahmed et al. Nutrients, 2017). The results are promising, and mobile health applications may represent a force multiplier for prolonged field research and behaviour change interventions, from prevention of injury and illness to delivery of military healthcare. However, significant concerns have been raised about data security with commercial health apps. We have therefore commenced the development of an app to coincide with the completion of the FEAT Study, to implement the behaviour changes highlighted or as a platform for further research that will be indicated.

5. What, in your opinion, present the biggest challenges to the development of ‘prolonged care’?

The PFC environment is largely undescribed, therefore prolonged field research is necessary to understand the challenges this environment provides. Such research could take place in training or operations. It should combine qualitative and quantitative approaches, to create a provider-centred depiction of the potential challenges and how these can be managed.

In area of interest, the critical factor not to miss is that prevention is better than cure, and ‘left of bang’ interventions begin at selection and training. The sex-differential in a variety of pertinent conditions, such as heat illness, stress fracture, post-traumatic stress disorder and infertility highlights that more can be done to understand and optimise physiology in order to develop mitigation strategies.

6. What are your priorities for the next year ahead?

Following the completion of the FEAT study, we aim to highlight the findings to policymakers, in order to implement effective preventative measures. It will be necessary to involve non-medical stakeholders and approach this creatively to avoid degrading the quality of training. Further research will also be required to better understand potential mitigating factors, such as the beneficial effects of sleep and strategies for coping with stress.

Medical Innovation attracts attendees from the military and civil healthcare community, from trainees to surgeons and scientists to policy makers, as well as industry suppliers of medical equipment and services. In your view, who/which professions will your session appeal to?

I very much hope policy makers, scientists with an interest in sports and nutrition physiology, trainees, and industry partners involve in mHealth might be interested in the session.

James Drake-Brockman, Divisional Director of Packaging Innovations and Luxury Packaging London, discusses the return of the UK’s most vibrant packaging event to Olympia London this September (12th & 13th).

What do you hope the audience will learn from this event?
Packaging professionals will have the opportunity to discover the latest trends, find new innovative suppliers to meet their packaging needs, network with peers and, of course, have an enjoyable day out.

The busy show floor will be complimented by a free-to-attend conference programme, as well as a host of interactive features and networking events, all designed to give visitors the tools and access they need to revitalise their packaging, increase brand awareness and boost the all-important sales.

 What discussions do you look forward to having with the attendees?
I’m always keen to understand more about the challenges that our visitors are facing. It is incredibly important for me to get under the skin of the community in order to ensure that our events consistently provide the most relevant, cutting-edge content and exhibitors. The packaging industry is constantly evolving, so we see the show as a vital opportunity to strengthen our relationships with the key players in the business and receive crucial feedback from the whole packaging community.

What do you enjoy most about your role?
I love connecting people and my role offers me the opportunity to do just that. My job enables me to bring the brightest minds in the industry together under one roof to network, discuss issues and come away better equipped to do their jobs. It’s very rewarding.

How did you get into the industry?
I fell into the events industry 19 years ago after leaving university and I have never looked back. It’s an exciting and challenging industry and offers an incredible sense of satisfaction when you put on a successful event. I joined the packaging industry around 18 months ago and have enjoyed getting to know the fantastic people in the industry, as well as discovering the challenges that the industry faces.

Where is your favourite place in the world and why?
My favourite place would have to be Café Nepenthe, Big Sur in California. It is an incredibly beautiful place and the spot where I proposed to my wife.

Register for of Packaging Innovations and Luxury Packaging London this September (12th & 13th)

Expert interview with Bernd Zeiss, Speaker of ‘Advantages of polymer syringes for demanding formulations’ Webinar.

What do you hope attendees will gain at your event/s?
I hope the attendees will get a deeper insight into the properties and advantages of prefillable COP syringes. The material is not really new anymore in the pharma primary packaging sector, but I still have the feeling pharma customers are a bit reluctant and cautious when it comes to materials other than glass. I want to give a deeper insight into the COP as a packaging material for parenterals, so the attendees feel more secure and comfortable with COP syringes.

What discussions do you look forward to having with the attendees?
COP syringes are widely used today, not only in the biotech field. I am looking forward to not only presenting COP syringes but also to get feedback if and why the syringes meet the requirements of pharma customers. Gerresheimer is always looking to improve its products. Besides sharing my knowledge I hope to get some input for improvements and new ideas from the attendees.

What do you enjoy most about your role?
In Technical Support you get a deep insight into quite a range of topics. Besides expanding my core expertise especially in biocompatibility and syringeability I have the chance to learn about the manufacturing of glass and polymer syringes, the Fill and Finish as well as the therapeutic background of injectable drugs.

How did you get into the industry?
I have been working in the primary packaging and pharma industry for already more than 15 years. As a natural scientist with a background in statistics, a clear customer focus and some curiosity the pharma packaging and medical device sectors never get boring. After university, I knew there is something out there I don´t know yet and that´s where I am going to work. So here I am.

Where is your favourite place in the world and why?
 I like travelling a lot, and I have been to many places in the world. Many travels are work related as Gerresheimer is a very international company. All countries and people have their specifics which I all appreciate. Yet my favourite place is at home, a small town in Germany not far from our glass syringe production site. That´s where I can make up my mind and create new ideas.

Join Bernd Zeiss on 27th September for a webinar entitled Avantages of polymer syringes for demanding formulations’ at 8:30 New York/2:30PM Germany

Expert interview with Terri Howard, speaker of ‘Transform Your Digital Content to Improve Speed to Market While Maintaining Compliance’ webinar.

What do you hope the audience will learn from this webinar?

I hope participants come away with an understanding of how the industry is responding to the increase in digital content creation and how efficiencies can be gained by properly managing their content. With Shawn Heuchan providing an inside look into Roche Diagnostics’ transformation, I believe the audience will take away a few actionable ideas they can bring to their own organization.

What discussions do you look forward to having with the audience?

I look forward to learning specific challenges that our audience has with digital marketing in their organization, whether from navigating complex global regulatory requirements, overcoming internal obstacles to change, or dealing with the pressure to gain the greatest value from each marketing campaign. Our goal is for the discussion to be interactive so that we can all bring our experiences into the conversation.

How did you get into the industry?

After spending the first part of my legal career helping businesses navigate complex rules in heavily-regulated industries such as finance, water resources, and international fishing, I decided to focus my attention in life sciences, being specifically drawn to the medical and diagnostic space. I knew that I would be rewarded every day, believing that my work and the work of my colleagues would contribute to the effort to improve or save lives around the world.

What do you enjoy most about your role?

Leading the strategic commercial initiatives of our company in the medical device space provides me with the opportunity to solve challenges, not only for Veeva, but more importantly for our customers. I enjoy the continued development of my expertise in the medical device space, and strive to help our customers achieve their strategic initiatives, even as the landscape continues to shift. My role is dynamic, exciting, and continues to challenge me in new ways.

Where is your favourite place in the world and why?

It is impossible to narrow this down to one place! I’ve been to 16 countries (which is apparently only 7.41% of the total available) and countless, amazing cities, towns and villages. I’ve enjoyed the beauty and elegance of Nyon, the mystique and artistry of Bali, the history and culture of London and the under (and over) water adventures in Hawaii.  My favourite place is always the last one I’ve visited.

Join Terri Howard on 18th July for a webinar entitled ‘Transform Your Digital Content to Improve Speed to Market While Maintaining Compliance‘ at 2PM London/3PM CEST

 

Expert interview with Robert Gaertner, speaker of ‘Transform Change Management with a Modern QMS’ webinar.

What do you hope the audience will learn from this webinar?

I expect that most of our audience will have a deep quality background and will be familiar with the basics of change management. So, the focus of this webinar is to provide practical advice.

The pharma industry is undergoing a transformation that has a significant impact on the effectiveness and efficiency of change management. This webinar will explore why change management needs to be modernized and key steps required to achieve this.

What discussions do you look forward to having with the audience?

I would like to understand what tactics quality units are currently applying to cope with the constantly increasing number of post-approval changes. And whether there is a more strategic approach to this where technology can support the process.

What do you enjoy most about your role?

It’s very easy – as Veeva’s strategy lead for quality in Europe, I have the unique opportunity to have a lot of interesting discussions on burning industry topics. This webinar is a good example!

How did you get into the industry?

There are a lot of life sciences companies in the region I’m from. My first student job was in a quality control lab and I joined the quality management department with the same company after graduating. It’s always good to learn things from the ground up!

Where is your favourite place in the world and why?

Definitely Barcelona! You wouldn’t find another large city in the world with the perfect combination of culture, beachfront, nightlife and good weather. There might be a reason why Veeva’s European Headquarters are located there!

Join Robert Gaertner on 19th July for a webinar entitled ‘Transform Change Management with a Modern QMS’ at 2PM London/3PM CEST

 

Daniel Döderlein, CEO, Auka

A conversation with Daniel Döderlein, CEO at Auka

Daniel is an award-winning serial entrepreneur with a background from several IT and Telecom startups. He founded one of Norway’s first domain and web hosting companies at the age of 17. A regular on the speaking circuit, Daniel has recently been invited to speak about upcoming banking disruption and mobile payments at Google Next in Europe, Paris fintech forum, Viva Tech and London Fintech Week.

BRW: What sets Auka apart from other fintechs? 

Generally we see a lot of fintechs applying “makeup” to their existing solutions. Some are successful, most are not. I believe that relates to a lack of problem solving. You have to find a problem and create a good solution backed by stellar execution. We defined our problem with the mobile payment solution we created. Enabling people and businesses to pay and get paid with ease, without any need for hardware. Digitising money and making it universally available and useful is our mission. The results so far speaks for themselves. We have served millions, empowered thousands of businesses, delivered financial results to the extent that we have paid out dividend to our shareholders. We have won multiple awards and have obtained and retained our own license since 2012. Our technology has been licensed by more than 100 financial institutions. I think that sets us apart from most fintechs

BRW: What are the advantages/disadvantages being a Norwegian fintech selling technology to banks in other regions?

Norway and the Nordics are stable, trustworthy and transparent countries. That resonates with our values and ways of business. I think this gives us an advantage as many companies out there over sell their solutions and abilities, while we focus on selling what we have proven already. Norwegians are known for being honest, straightforward and to the point. I hope and feel that our current and future customers value that. This attitude saves them time, getting to the important points faster. The Nordics also have a good list of successful companies – including many unicorns in the technology – and financial services sector. As a small region with a higher success rate than many other regions on average, we benefit from high quality attention and conversations from the get go.

BRW: Most banks accept that third parties will provide banking services to consumers. Accepting that, what are the three main challenges facing banks?

1. Someone else will become the primary interface that customers use to deal with their financial services.
2. Someone else will know more about the customer, making it harder for the bank to see the whole picture vs. what the third parties may be able to.
3. With more players in the market, there will be more choice for the customer to choose from. This means banks must innovate and compete on product diversification vs. the commodity service sales they have mastered. This requires a fundamental shift in mindset and culture, and that takes time

BRW: You are known to be more than willing to predict the future in banking. How can you be sure that Auka have the solutions to help bank prosper in the future?

Predicting the future for mobile payments is not that hard. In fact we are not predicting it, we have built it and proven it already. What we are saying is that what has already happened in the most mature markets will eventually happen everywhere. So we lean on facts, giving potential customers a glimpse of their own future based on what has happened elsewhere. Learning from this we have figured out that the best way to predict the future is to create it. We have done that once, and will continue to do it for the next generation of services, also for what’s next, after mobile payments.

BRW: Why do you believe banks are best positioned to keep dominating financial services? 

Again because its been proven in the Nordics. In China the banks could have done their own AliPay, but they did not. So Alipay did it. Now that has become the downfall for the Chinese banks, at least in terms of payments and commerce enablement. So if the banks do what has been done before, but fast, they can win the attention of the customers. This is the first frontier but they need to act fast.

BRW: There’s loads of webinars every month on this subject. Why should bankers listen in on this one?

We are sharing facts and experiences from the most successful markets. These are not predictiona but valuable insights from the movers and shakers who have already transformed the most modern markets on the face of the planet. Also we have a great panel, that should make this not only useful, but also funny, dynamic and interesting.

Join Daniel Döderlein on 14th June for a webinar entitledProfiting From Mobile Payments: How Do Banks Make Money From Mobile Wallets?’ at 3PM London/10AM New York

Register Here!

Aaron Lloyd – Toxicology Laboratory Manager at Wickham Laboratories Ltd.

A conversation with Aaron Lloyd, Toxicology Laboratory Manager at Wickham Laboratories Ltd.

Aaron Lloyd first joined Wickham Laboratories as an Animal Technician in 2001 and was subsequently promoted over the years to varying levels of responsibility within the department.

Currently, he acts as the Laboratory Manager for Toxicology and In Vitro Research, with oversight of the company’s medical device project licenses for USP Plastics Class I-VI and the ISO 10993 series.

His degree was gained at the University of Portsmouth in 1999 in Biology, with specific areas of study including Parasitology, Immunology, Evolution, Animal Diversity, and Marine Biology.

BRW: How did you get into the industry?

I went to University to study biology as I had always loved science and thought that I would want to pursue a career along those lines. I had worked a few jobs when the opportunity to move to WLL came about. Working in what is essentially a medical industry appealed to me and the diversity of the role means I have never looked back.

BRW: What do you like most about your role?

I really enjoy working closely with clients bringing their drugs and devices to market. Often a detailed approach is required to test products suitably and even when a straight forward pharmacopeia test is required, we will still spend time trying to refine methods to make them as ethical as possible with regards to the 3Rs.

BRW: What do you hope the audience will learn from this webinar?

I hope that the audience will see that even though it appears from the ISOs that there is a strict testing regime there is still plenty of consideration to best approach. Literature research and device evaluation can lead to test reduction, which is a massive ethical gain and great for the client’s finances.

BRW: What discussions do you look forward to having with the audience?

I will be interested to hear of any novel or difficult devices the audience has had experience of trying to bring to the market. We may not have all the answers straight away but one of the interesting aspects of a role like this is the challenge of these materials and the satisfaction of finding a solution.

Join Aaron Lloyd and Wickham Laboratories Ltd. on 23rd May for their webinar “Regulatory Changes in Medical Device Development” at 3PM London/10AM New York.